Louise Slaughter: “I can't stress enough the urgency of absolutely making sure our current stock of antibiotics does not become obsolete.”

I think innovation was very much at the heart of the complaint we filed against Facebook, right, that was not a price complaint.

Yes, so I think for a long time there has been a general sense in the antitrust world that vertical mergers are rarely bad, and in fact, may be mostly good.

Please, please do not let the NEA get killed. I feel like I have been begging you forever.

I am really excited about the opportunity to take a fresh look at a broader range of questions in pharmaceutical mergers than our traditional approach has taken.